These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18795882)

  • 21. The necessity to develop drugs against parasitic diseases.
    Kaiser A; Gottwald A; Wiersch C; Maier W; Seitz HM
    Pharmazie; 2002 Nov; 57(11):723-8. PubMed ID: 12611273
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Editorial: Innovative Therapeutic and Immunomodulatory Strategies for Protozoan Infections.
    Gómez Marín JE; El Bissati K
    Front Cell Infect Microbiol; 2019; 9():293. PubMed ID: 31448246
    [No Abstract]   [Full Text] [Related]  

  • 23. High-throughput Plasmodium falciparum growth assay for malaria drug discovery.
    Baniecki ML; Wirth DF; Clardy J
    Antimicrob Agents Chemother; 2007 Feb; 51(2):716-23. PubMed ID: 17116676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metal nanoparticles restrict the growth of protozoan parasites.
    Adeyemi OS; Molefe NI; Awakan OJ; Nwonuma CO; Alejolowo OO; Olaolu T; Maimako RF; Suganuma K; Han Y; Kato K
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S86-S94. PubMed ID: 30033773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New chemotherapeutic strategies against malaria, leishmaniasis and trypanosomiases.
    Zucca M; Scutera S; Savoia D
    Curr Med Chem; 2013; 20(4):502-26. PubMed ID: 23210775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomics and its impact on parasitology and the potential for development of new parasite control methods.
    Ellis JT; Morrison DA; Reichel MP
    DNA Cell Biol; 2003 Jun; 22(6):395-403. PubMed ID: 12906733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bis(2-aminoimidazolines) and Bisguanidines: Synthetic Approaches, Antiparasitic Activity and DNA Binding Properties.
    Dardonville C; Martínez JJN
    Curr Med Chem; 2017; 24(33):3606-3632. PubMed ID: 28641558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug repurposing and human parasitic protozoan diseases.
    Andrews KT; Fisher G; Skinner-Adams TS
    Int J Parasitol Drugs Drug Resist; 2014 Aug; 4(2):95-111. PubMed ID: 25057459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-reactivity between antibodies in the sera of individuals with leishmaniasis, toxoplasmosis, and Chagas' disease and antigens of the blood-stage forms of Plasmodium falciparum determined by indirect immunofluorescence.
    Abramo C; Fontes CJ; Krettli AU
    Am J Trop Med Hyg; 1995 Aug; 53(2):202-5. PubMed ID: 7677225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dithiol proteins as guardians of the intracellular redox milieu in parasites: old and new drug targets in trypanosomes and malaria-causing plasmodia.
    Krauth-Siegel RL; Bauer H; Schirmer RH
    Angew Chem Int Ed Engl; 2005 Jan; 44(5):690-715. PubMed ID: 15657967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative analysis of the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi.
    Parsons M; Worthey EA; Ward PN; Mottram JC
    BMC Genomics; 2005 Sep; 6():127. PubMed ID: 16164760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New trends in chemotherapy on human and animal blood parasites.
    Schrével J; Millerioux V; Sinou V; Frappier F; Santus R; Grellier P
    Parasitol Res; 1996; 82(3):283-4. PubMed ID: 8801568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Natural products as trypanocidal, antileishmanial and antimalarial drugs.
    Fournet A; Muñoz V
    Curr Top Med Chem; 2002 Nov; 2(11):1215-37. PubMed ID: 12171582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Parasite Polyamines as Pharmaceutical Targets.
    Roberts S; Ullman B
    Curr Pharm Des; 2017; 23(23):3325-3341. PubMed ID: 28571553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular tools for analysis of gene function in parasitic microorganisms.
    Meissner M; Agop-Nersesian C; Sullivan WJ
    Appl Microbiol Biotechnol; 2007 Jul; 75(5):963-75. PubMed ID: 17401559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trypanosomatid comparative genomics: Contributions to the study of parasite biology and different parasitic diseases.
    Teixeira SM; de Paiva RM; Kangussu-Marcolino MM; Darocha WD
    Genet Mol Biol; 2012 Jan; 35(1):1-17. PubMed ID: 22481868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
    Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
    J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of New Inhibitors of Toxoplasma gondii via the Pathogen Box.
    Spalenka J; Escotte-Binet S; Bakiri A; Hubert J; Renault JH; Velard F; Duchateau S; Aubert D; Huguenin A; Villena I
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133550
    [No Abstract]   [Full Text] [Related]  

  • 39. Protein kinases as targets for anti-parasitic chemotherapy.
    Doerig C
    Biochim Biophys Acta; 2004 Mar; 1697(1-2):155-68. PubMed ID: 15023358
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.